PRESS RELEASE published on 02/13/2025 at 07:30, 1 year 6 months ago TAKKT generates strong free cash flow and further stabilizes sales development in the fourth quarter TAKKT AG achieves strong free cash flow and stable sales development in Q4 2024, meeting upper end of forecasts. Proposed dividend of EUR 0.60 per share. Future focus on organic growth and improved EBITDA margin EBITDA Margin Dividend Free Cash Flow TAKKT AG Sales Development
BRIEF published on 12/03/2024 at 16:46, 1 year 8 months ago Andreas Weishaar nommé PDG de TAKKT AG TAKKT AG Leadership Stratégique Nomination Du PDG Amélioration Opérationnelle Andreas Weishaar
BRIEF published on 12/03/2024 at 16:46, 1 year 8 months ago Andreas Weishaar Appointed CEO of TAKKT AG CEO Appointment Operational Improvement TAKKT AG Strategic Leadership Andreas Weishaar
PRESS RELEASE published on 12/03/2024 at 16:41, 1 year 8 months ago TAKKT AG: Andreas Weishaar appointed as Chief Executive Officer of TAKKT AG Andreas Weishaar appointed as Chief Executive Officer of TAKKT AG. The Supervisory Board confirms his role to drive operational and strategic progress in the company Supervisory Board CEO TAKKT AG Management Andreas Weishaar
BRIEF published on 10/24/2024 at 07:35, 1 year 10 months ago TAKKT Reports Improved Sales and Earnings in Third Quarter Long-term Strategy Cost Management Sales Improvement TAKKT Earnings Challenges Resolved
BRIEF published on 10/24/2024 at 07:35, 1 year 10 months ago TAKKT annonce une amélioration de ses ventes et de ses bénéfices au troisième trimestre Stratégie À Long Terme Gestion Des Coûts Bénéfices De TAKKT Amélioration Des Ventes Défis Résolus
PRESS RELEASE published on 10/24/2024 at 07:30, 1 year 10 months ago TAKKT records improved sales and earnings development in the third quarter and focuses on long-term success TAKKT AG reports improved sales and earnings in Q3 despite challenges. Prioritizes order intake and cash flow. Cost management to boost profitability. Long-term success focus Sales Cash Flow Order Intake Earnings TAKKT AG Q3
BRIEF published on 10/22/2024 at 13:47, 1 year 10 months ago TAKKT AG abaisse ses prévisions de bénéfices pour 2024 malgré des gains au troisième trimestre Marge EBITDA TAKKT AG Taux De Croissance Troisième Trimestre Prévisions De Rentabilité
BRIEF published on 10/22/2024 at 13:47, 1 year 10 months ago TAKKT AG Lowers Profit Forecast for 2024 Despite Third Quarter Gains EBITDA Margin TAKKT AG Growth Rate Third Quarter Profitability Forecast
PRESS RELEASE published on 10/22/2024 at 13:42, 1 year 10 months ago EQS-Adhoc: TAKKT AG: Despite improvements in the third quarter, TAKKT expects lower profitability in the final quarter and adjusts guidance for 2024 TAKKT AG expects lower profitability despite improvements in Q3 and adjusts guidance for 2024. Organic growth rate and EBITDA margin increased in Q3 Profitability EBITDA Margin TAKKT AG Guidance Adjustment Organic Growth Rate
Published on 08/26/2026 at 23:00, 13 minutes ago Datametrex Announces Transition to Semi-Annual Financial Reporting
Published on 08/26/2026 at 22:30, 43 minutes ago AI/ML Innovations Inc. Closes First Tranche of Private Placement
Published on 08/26/2026 at 22:30, 43 minutes ago Blueberries Medical Announces Closing of C$1.1 Million Non-Brokered Private Placement
Published on 08/26/2026 at 21:15, 1 hour 58 minutes ago Announces Private Placement of Convertible Promissory Notes
Published on 08/26/2026 at 20:35, 2 hours 38 minutes ago RUM Reports Quarterly Financial Results for June 30, 2026
Published on 08/26/2026 at 23:05, 8 minutes ago Biosidus expands biologics manufacturing capacity and strengthens global supply capabilities for agalsidase beta
Published on 08/26/2026 at 18:44, 4 hours 28 minutes ago AUSTRIACARD HOLDINGS AG: Press Release H1 2026 Financial Results
Published on 08/26/2026 at 18:40, 4 hours 33 minutes ago MBC GROUP REVEALS MBC GAMES STUDIO WITH DEBUT TITLE UNVEILING AT GAMESCOM
Published on 08/26/2026 at 18:30, 4 hours 43 minutes ago Heidelberg Pharma AG and Huadong Medicine Receive NMPA Approval for Clinical Trial of HDP-101 Combination Therapy in China
Published on 08/26/2026 at 18:00, 5 hours 13 minutes ago MHM Corporate: reduces the nominal value of its shares to €0.011
Published on 08/26/2026 at 18:02, 5 hours 11 minutes ago Altareit: Altarea press release regarding the Primonial matter
Published on 08/26/2026 at 18:02, 5 hours 11 minutes ago Altareit : Communiqué de presse d’Altarea relatif au dossier Primonial
Published on 08/26/2026 at 18:00, 5 hours 13 minutes ago Altarea: Comprehensive settlement agreement reached, ending the dispute between Altarea and the shareholders of the Praemia group (formerly Primonial group)
Published on 08/26/2026 at 18:00, 5 hours 13 minutes ago Altarea : Conclusion d’un accord global mettant fin au litige entre Altarea et les actionnaires du groupe Praemia (ex-groupe Primonial)
Published on 08/26/2026 at 18:00, 5 hours 13 minutes ago KLARSEN : lance Dimea, sa nouvelle activité e-commerce dédiée aux compléments alimentaires